Status:
UNKNOWN
Exploring Interactions Between Growth Hormone and the Microbiome
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Weizmann Institute of Science
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
3-18 years
Brief Summary
The goal of this study is to characterize the microbiome and metabolomics of children with Growth Hormone (GH) deficiency, prior GH treatment initiation and compare it to healthy children
Eligibility Criteria
Inclusion
- Children with GH deficiency
Exclusion
- Turner syndrome
- End state renal disease (ESRD)
- Prader-Willi syndrome
- Systemic illness
- Antibiotics/Antifungal in the last 3m
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03327207
Start Date
November 1 2017
End Date
November 1 2021
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric endocrinology unit rambam medical center
Haifa, Israel